Suppr超能文献

早期联合检测N末端脑钠肽前体和心肌肌钙蛋白T对失代偿性心力衰竭患者长期风险分层的重要性。

Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.

作者信息

Perna Eduardo R, Macin Stella M, Cimbaro Canella Juan P, Szyszko Ariel, Franciosi Valeria, Vargas Morales Walter, Bayol Augusto P, Kriskovich Jorge O, Medina Fernanda, Gonzalez Arjol Bilda, Brizuela Monica

机构信息

Heart Failure Clinic, Instituto de Cardiologia J. F. Cabral, Corrientes, Argentina.

出版信息

J Heart Lung Transplant. 2006 Oct;25(10):1230-40. doi: 10.1016/j.healun.2006.08.004.

Abstract

BACKGROUND

Markers of myocardial necrosis and natriuretic peptides are risk predictors in decompensated heart failure (DHF). We prospectively studied the optimal timing of combined cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) measurements for long-term risk stratification.

METHODS

cTnT and NT-proBNP were measured upon admission, and before discharge in 76 patients hospitalized for DHF (mean age 62.3 +/- 15 years; 71% men).

RESULTS

During a mean follow-up of 252 +/- 120 days, 39.5% of patients died or were re-hospitalized for DHF. From receiver-operator-characteristic (ROC) curves, the selected cut-off values for cTnT and NT-proBNP were 0.026 ng/ml and 3,700 pg/ml on admission, and 0.030 ng/ml and 3,200 pg/ml, respectively, at discharge. Depending upon measurements above vs below cut-off, the population was distributed on admission and before discharge for three groups: both negative (24% and 30% of patients); one positive (43% and 42%); and both positive (33% and 28%). For the admission groups, the 1-year DHF-free re-hospitalization survival rates were 85%, 60% and 34%, respectively (p = 0.0047). One-year survival rates for DHF-free re-hospitalization were 63%, 71% and 26% (p = 0.0029), respectively, for the discharge groups. In the Cox proportional hazards model, systolic blood pressure (hazard ratio [HR]: 0.98; 95% confidence interval [CI]: 0.96 to 0.99), heart rate (HR: 0.97; 95% CI: 0.94 to 0.98), one positive biomarker on admission (HR: 10.5; 95% CI: 1.3 to 83.7) and two positive biomarkers on admission (HR: 13.9; 95% CI: 1.8 to 98.5) were independent predictors of long-term outcomes. However, NT-proBNP on admission was the most important predictor of long-term prognosis (HR: 5.1; 95% CI: 2.3 to 12.2).

CONCLUSIONS

The combined measurements of cTnT and NT-proBNP on hospital admission were more reliable than their measurements before discharge in the long-term risk stratification of DHF. A single positive measurement on admission predicted a poor long-term outcome.

摘要

背景

心肌坏死标志物和利钠肽是失代偿性心力衰竭(DHF)的风险预测指标。我们前瞻性地研究了联合检测心肌肌钙蛋白T(cTnT)和N末端脑钠肽前体(NT-proBNP)用于长期风险分层的最佳时机。

方法

对76例因DHF住院的患者(平均年龄62.3±15岁;71%为男性)在入院时及出院前检测cTnT和NT-proBNP。

结果

在平均252±120天的随访期间,39.5%的患者死亡或因DHF再次住院。根据受试者工作特征(ROC)曲线,入院时cTnT和NT-proBNP的选定临界值分别为0.026 ng/ml和3700 pg/ml,出院时分别为0.030 ng/ml和3200 pg/ml。根据检测值高于或低于临界值,将患者在入院时和出院前分为三组:两者均为阴性(分别占患者的24%和30%);一项为阳性(分别占43%和42%);两者均为阳性(分别占33%和28%)。对于入院分组,1年无DHF再住院生存率分别为85%、60%和34%(p = 0.0047)。对于出院分组,1年无DHF再住院生存率分别为63%、71%和26%(p = 0.0029)。在Cox比例风险模型中,收缩压(风险比[HR]:0.98;95%置信区间[CI]:0.96至0.99)、心率(HR:0.97;95%CI:0.94至0.98)、入院时一项生物标志物为阳性(HR:10.5;95%CI:1.3至83.7)和入院时两项生物标志物为阳性(HR:13.9;95%CI:1.8至98.5)是长期预后的独立预测因素。然而,入院时的NT-proBNP是长期预后的最重要预测因素(HR:5.1;95%CI:2.3至12.2)。

结论

在DHF的长期风险分层中,入院时联合检测cTnT和NT-proBNP比出院前检测更可靠。入院时单项检测为阳性预示长期预后不良。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验